Safety Information
| Description | Publish Date | LINKS |
|---|---|---|
| Salbutamol pMDI, Risk Awareness Dialogue Aid | 05/01/2026 |  |
| Salbutamol pMDI, Advisory Letter | 15/10/2025 |
|
| Cabotegravir Patient appointment reminder card | 01/08/2024 | |
| Cabotegravir Patient educational brochure | 01/08/2024 | |
| Cabotegravir Provider checklist | 01/08/2024 | |
| Cabotegravir Provider educational brochure | 01/08/2024 | |
| Important safety information on Dolutegravir in Botswana |
10/10/2018 |
|
| Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck | 15/06/2024 | |
| Important safety information on Fluticasone Furoate nasal spray - EMA, Dysphonia, aphonia, dysgeusia, ageusia and anosmia | 05/12/2024 | |
| Important safety information on Rotarix - ANSM, Gastroenteritis and vomiting | 18/10/2024 | |
| Important safety information on Cabotegravir containing products - EMA, SJS, TEN, Gait disturbance | 14/10/2024 | |
| Important safety information on Paroxetine containing products - Israel HA, Black Box Warning to SSRIs and SNRIs | 26/07/2024 |
|
| Important safety information on Paroxetine containing products - Medsafe, Co-ingestion of SSRIs/SNRIs with alcohol in overdose and suicide | 24/06/2024 |
|
| Important safety information on Paroxetine containing products - Medsafe, Medicine-induced hyponatraemia: increased risks in older people | 16/06/2024 | |
| Important safety information on Amoxicillin/clavulanic acid containing products - SAPHRA, Risk of linear IgA | 23/05/2024 | |
| Important safety information on Amoxicillin/clavulanic acid containing products - SAPHRA, Risk of of Kounis syndrome | 23/05/2024 | |
Important safety information on Abacavir containing products - Regarding amendments to the instructions for medical use of medicines containing abacavir |
19/03/2024 | |
Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Botswana |
09/09/2023 | |
Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe communication regarding labelling updates |
19/12/2023 | |
| Important safety information on Dolutegravir containing products in Botswana (Safety Notification_Korean label update for Dolutegravir containing products) | 02-11-2023 | |
Important safety information on Paroxetine containing products - Modifications of the information of medicines authorized by national procedure that contain Paroxetine |
27/12/2023 | |
| Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe, Vanishing bile duct syndrome (VBDS) | 19/12/2023 | |
